Drug and Alcohol Dependence
Volume 91, Issue 2 , Pages 141-148 , 1 December 2007

A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence

  • Theresa Winhusen

      Affiliations

    • Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
    • Cincinnati Addictions Research Center (CinARC), 3210 Jefferson Avenue, Cincinnati, OH 45220, USA
    • Corresponding Author InformationCorresponding author at: University of Cincinnati, 3210 Jefferson Avenue, Cincinnati, OH 45220, USA.
    • ,
  • Eugene Somoza

      Affiliations

    • Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
    • Cincinnati Addictions Research Center (CinARC), 3210 Jefferson Avenue, Cincinnati, OH 45220, USA
    • Veterans Affairs Medical Center (VISN 10), 3200 Vine Street, Cincinnati, OH 45220, USA
    • ,
  • Domenic A. Ciraulo

      Affiliations

    • Department of Psychiatry, Boston Medical Center and Boston University School of Medicine, 720 Harrison Ave, Boston, MA 02118, USA
    • ,
  • Judy M. Harrer

      Affiliations

    • Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
    • Veterans Affairs Medical Center (VISN 10), 3200 Vine Street, Cincinnati, OH 45220, USA
    • ,
  • R. Jeffrey Goldsmith

      Affiliations

    • Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
    • Veterans Affairs Medical Center (VISN 10), 3200 Vine Street, Cincinnati, OH 45220, USA
    • ,
  • John Grabowski

      Affiliations

    • Substance Abuse Research Center, Department of Psychiatry and Behavioural Sciences, University of Texas-Health Science Center at Houston, 1300 Moursund Street, Houston, TX 77030, USA
    • ,
  • Florence S. Coleman

      Affiliations

    • Mental Health (116); Dayton VA Medical Center, 4100 West Third Street, Dayton, OH 45428, USA
    • ,
  • Gordon Mindrum

      Affiliations

    • Cincinnati Addictions Research Center (CinARC), 3210 Jefferson Avenue, Cincinnati, OH 45220, USA
    • ,
  • Roberta Kahn

      Affiliations

    • National Institute on Drug Abuse, Division of Treatment Research and Development, 6001 Executive Blvd, Rm 4123, Bethesda, MD 20892, USA
    • ,
  • Sabuhi Osman

      Affiliations

    • Cincinnati Addictions Research Center (CinARC), 3210 Jefferson Avenue, Cincinnati, OH 45220, USA
    • ,
  • Juris Mezinskis

      Affiliations

    • Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
    • Veterans Affairs Medical Center (VISN 10), 3200 Vine Street, Cincinnati, OH 45220, USA
    • ,
  • Shou-Hua Li

      Affiliations

    • National Institute on Drug Abuse, Division of Treatment Research and Development, 6001 Executive Blvd, Rm 4123, Bethesda, MD 20892, USA
    • ,
  • Daniel Lewis

      Affiliations

    • Cincinnati Addictions Research Center (CinARC), 3210 Jefferson Avenue, Cincinnati, OH 45220, USA
    • ,
  • Paul Horn

      Affiliations

    • Cincinnati Addictions Research Center (CinARC), 3210 Jefferson Avenue, Cincinnati, OH 45220, USA
    • Veterans Affairs Medical Center (VISN 10), 3200 Vine Street, Cincinnati, OH 45220, USA
    • Department of Mathematics, University of Cincinnati, 2693 Campus Drive, Cincinnati, OH 45221, USA
    • ,
  • Margaret A. Montgomery

      Affiliations

    • National Institute on Drug Abuse, Division of Treatment Research and Development, 6001 Executive Blvd, Rm 4123, Bethesda, MD 20892, USA
    • ,
  • Ahmed Elkashef

      Affiliations

    • National Institute on Drug Abuse, Division of Treatment Research and Development, 6001 Executive Blvd, Rm 4123, Bethesda, MD 20892, USA

Received 29 March 2007 ,Revised 16 May 2007 ,Accepted 17 May 2007.

References 

  1. Adkins JC, Noble S. Tiagabine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy. Drugs. 1998;55:437–460
  2. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin FH. One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch. Gen. Psychiatry. 1994;51:989–997
  3. Cone EJ. Pharmacokinetics and pharmacodynamics of cocaine. J. Anal. Toxicol. 1995;19(6):459–478
  4. Cousins MS, Roberts DC, de Wit H. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend. 2002;65:209–220
  5. Campbell UC, Lac ST, Carroll ME. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology. 1999;143:209–214
  6. Dewey SL, Chaurasia CS, Chen CE, Volkow ND, Clarkson FA, Porter SP, et al. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse. 1997;25:350–356
  7. Fals-Stewart W, O’Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J. Consult. Clin. Psychol. 2000;68:134–144
  8. González G, Desai R, Sofuoglu M, Poling J, Olivito A, Gonsai K, et al. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 2007;87:1–9
  9. González G, Severino K, Sofuoglu M, Poling J, Olivito A, Gonsai K, et al. Tiagabine increases cocaine (benzoylecgonine) free urines in recently admitted cocaine-dependent methadone treated patients: preliminary results of a randomized clinical trial. Addiction. 2003;98:1625–1632
  10. Kang SY, Kleinman PH, Woody GE, Millman RB, Todd TC, Kemp J, et al. Outcomes for cocaine abusers after once-a-week psychosocial therapy. Am. J. Psychiatry. 1991;148:630–635
  11. Koob GF, Nestler EJ. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 1997;9:482–497
  12. Kushner SA, Dewey SL, Kornetsky C. Comparison of the effects of vagabatrin on cocaine self-administration and food reinforcement. Soc. Neurosci. 1997;1942;(Meeting Abstracts)
  13. Kushner SA, Dewey SL, Kornetsky C. The effects of gamma-vinyl GABA on cocaine-induced lowering of brain-stimulation reward thresholds. Pychopharmacology. 1997;133:383–388
  14. Leach JP, Sills GJ, Butler E, Forrest G, Thompson GG, Brodie MJ. Neurochemical actions of vigabatrin and tiagabine alone and in combination in mouse cortex. Gen. Pharmacol. 1997;28:715–719
  15. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the Addiction Severity Index. J. Subst. Abuse Treat. 1992;9:199–213
  16. Mezinskis J, Dryenforth S, Goldsmith R, Cohen R, Somoza E. Craving and withdrawal symptoms for various drugs of abuse. Psychiatr. Ann. 1998;28:577–583
  17. Morgan AE, Dewey SL. Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse. 1998;28:60–65
  18. Preston KL, Silverman K, Schuster CR, Cone EJ. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction. 1997;92:717–727
  19. SAS Institute Inc. SAS/STAT software, Version 9.1 of the SAS System for Microsoft Windows. Copyright © (2002–2003), Cary, NC, USA: SAS Institute Inc.
  20. Sobell LC, Sobell MB. Timeline follow back: a technique for assessing self-reported ethanol consumption. In:  Allen J,  Lit-ten R editor. Techniques to Assess Alcohol Consumption. New Jersey: Humana Press, Inc; 1992;p. 19–28
  21. Schachter SC. Tiagabine monotherapy in the treatment of partial epilepsy. Epilepsia. 1995;36(Suppl. 6):S2–S6
  22. Thisted RA. Elements of Statistical Computing. New York: Chapman and Hall; 1988;
  23. Tracy K, Baker S, LoCastro J, Mezinskis J, Simon S, Somoza E. The Substance Clinical Global Impression (SCGI) Scale: measuring global functioning in substance related clinical trials. NIDA Res Mon. 2000;180
  24. Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: the state of the science. Am. J. Psychiatry. 2005;162:1432–1440
  25. Winhusen T, Somoza E, Harrer J, Mezinskis J, Montgomery M, Goldsmith R, et al. A placebo-controlled screening trial of tiagabine, sertraline, and donepezil as cocaine dependence treatments. Addiction. 2005;100(Suppl. 1):68–77

PII: S0376-8716(07)00238-4

doi: 10.1016/j.drugalcdep.2007.05.028

Drug and Alcohol Dependence
Volume 91, Issue 2 , Pages 141-148 , 1 December 2007

Article Tools

* Image Usage & Resolution